In vitro and in vivo activities of NS-718, a new lipid nanosphere incorporating amphotericin B, against aspergillus fumigatus

Antimicrobial Agents and Chemotherapy

Volumn 43, Issue 3, 1999, Pages 471-475

  Otsubo, Takakazu ^a   Maesaki, Shigefumi ^a   Hossain, Mohammad Ashraf ^a   Yamamoto, Yoshihiro ^a   Tomono, Kazunori ^a   Tashiro, Takayoshi ^a   Seki, Junzo ^b   Tomii, Yoshifumi ^b   Sonoke, Satoru ^b   Kohno, Shigeru ^a  

^a NAGASAKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b NIPPON SHINYAKU CO LTD   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B DEOXYCHOLATE; AMPHOTERICIN B LIPID COMPLEX; ANTIFUNGAL AGENT; DRUG CARRIER; LIPID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ASPERGILLUS FUMIGATUS; CONTROLLED STUDY; DOSE RESPONSE; DRUG BLOOD LEVEL; DRUG EFFICACY; DRUG FORMULATION; DRUG POTENCY; LUNG ASPERGILLOSIS; MALE; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; RAT;

EID: 0033055835     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.43.3.471     Document Type: Article

References (21)

1. Clark, J. M., R. R. Whitney, S. J. Olsen, R. J. George, M. R. Swerdel, L. Kunselman, and D. P. Bonner. 1991. Amphotericin B lipid complex therapy of experimental fungal infections in mice. Antimicrob. Agents Chemother. 35:615-621.
2. Espuelas, M. S., P. Legrand, J. M. Irache, C. Gamazo, A. M. Orecchioni, J. P. Devissaguet, and P. Ygartua. 1997. Poly (ε-caprolacton) nanoparticles as an alternative way to reduce amphotericin B toxicity. Int. J. Pharm 158:19-27.
3. Fielding, R. M., P. C. Smith, L. H. Wang, J. Porter, and L. S. Guo. 1991. Comparative pharmacokinetics of amphotericin B after administration of a novel colloidal delivery system, ABCD, and a conventional formulation to rats. Antimicrob. Agents Chemother. 35:1208-1213.
4. Fukui, H., T. Koike, A. Saheki, S. Sonoke, H. Yoshikawa, H. Sasaki, Y. Tomii, and J. Seki. 1996. A novel antifungal drug delivery system: lipid nanosphere incorporating amphotericin B (LNS-AmB). abstr. 5026, p. 655. In Proceedings of the 23rd International Symposium on Controlled Release of Bioactive Materials.
5. Granich, G. G., G. S. Kobayashi, and D. J. Krogstad. 1986. Sensitive high-pressure liquid chromatographic assay for amphotericin B which incorporates an internal standard. Antimicrob. Agents Chemother. 29:584-588.
6. Hay, R. J. 1994. Liposomal amphotericin B, AmBisome. J. Infect. 28(Suppl. I):35-43.
7. Hossain, M. A., S. Maesaki, H. Kakeya, T. Noda, K. Yanagihara, E. Sasaki, Y. Hirakata, K. Tomono, T. Tashiro, and S. Kohno. 1998. Efficacy of NS-718, a novel lipid nanosphere-encapsulated amphotericin B, against Cryptococcus neoformans. Antimicrob. Agents Chemother. 42:1722-1725.
8. Kohno, S., T. Otsubo, K. Hara, Y. Tomii, and J. Seki. 1995. A new antifungal drug delivery system, lipid nanosphere encapsulating amphotericin B (LNS-AmB). its evaluation in the rat model of invasive pulmonary aspergillosis, abstr. 109, p. 131. In Program and abstracts of the 35th Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology, Washington, D.C.
9. Kohno, S., K. Hara, N. Murahashi, and T. Watanabe. 1991. Amphotericin B incorporated in lipid emulsion (lipid microsphere), p. 333-339. In H. Yamaguchi, G. S. Kobayashi, and H. Takahashi (ed.). Recent progress in antifungal chemotherapy. Marcel Dekker, Inc., New York, N.Y.
10. Kohno, S., T. Miyazaki, K. Yamaguchi, H. Tanaka, T. Hayashi, M. Hirota, A. Saito, K. Hara, T. Sato, and J. Sunamoto. 1988. Polysaccharide-coated liposomes with antimicrobial agents against intracytoplasmic pathogens and fungi. J. Bioact. Compat. Polym. 3:137-147.
11. Legrand, P., E. A. Romero, B. E. Cohen, and J. Bolard. 1992. Effect of aggregation and solvent on the toxicity of amphotericin B to human erythrocytes. Antimicrob. Agents Chemother. 36:2518-2522.
12. Matsuda, H., S. Kohno, S. Maesaki, H. Yamada, H. Koga, M. Tamura, H. Kuraishi, and J. Sugiyama. 1992. Application of ubiquinone systems and electrophoretic comparison of enzymes to identification of clinical isolates of Aspergillus fumigatus and several other species of Aspergillus. J. Clin. Microbiol. 30:1999-2005.
13. Mitsutake, K., S. Kohno, Y. Miyazaki, T. Noda, H. Miyazaki, T. Miyazaki, M. Kaku, H. Koga, and K. Hara. 1994. In vitro and in vivo antifungal activities of liposomal amphotericin B, and amphotericin B lipid complex. Mycopathologia 128:13-17.
14. Miyazaki, H., S. Kohno, Y. Miyazaki, K. Mitsutake, K. Tomono, M. Kaku, H. Koga, and K. Hara. 1993. Efficacy of intravenous itraconazole against experimental pulmonary aspergillosis. Antimicrob. Agents Chemother. 37:2762-2765.
15. Mizushima, Y. 1991. Lipo-prostaglandin preparations. Prostaglandins Leukot. Essent. Fatty Acids 42:1-6.
16. Mizushima, Y., T. Hamano, and K. Yokoyama. 1982. Use of a lipid emulsion as a novel carrier for corticosteroids. J. Pharm. Pharmacol. 34:49-50.
17. Mizushima, Y., Y. Wada, Y. Etoh, and K. Watanabe. 1983. Anti-inflammatory effects of indomethacin ester incorporated in a lipid microsphere. J. Pharm. Pharmacol. 35:398-399.
18. National Committee for Clinical Laboratory Standards. 1997. Reference method for broth dilution antifungal susceptibility testing of yeasts. Approved standard M27-A. National Committee for Clinical Laboratory Standards. Wayne, Pa.
19. Pahls, S., and A. Schaffner. 1994. Comparison of the activity of free and liposomal amphotericin B in vitro and in a model of localized murine candidiasis. J. Infect. Dis. 169:1057-1061.
20. Seki, J., H. Sasaki, M. Doi, H. Yoshikawa, Y. Takahashi, S. Yamane, H. Fukui, S. Sonoke, H. Yamamoto, M. Hirose, Y. Ezure, T. Ando, K. Ushimaru, and M. Sugiyama. 1994. Lipid nanosphere (LNS), a protein free analogue of lipoproteins, as a novel drug carrier for parenteral administration. J. Controlled Release 28:352-353.
21. Van Etten, E. W. M., C. Van den Heuvel-de Groot, and I. A. J. M. Bakker-Woudenberg. 1993. Efficacies of amphotericin B-deoxycholate (Fungizone). liposomal amphotericin B (AmBisome) and fluconazole in the treatment of systemic candidosis in immunocompetent and leukopenic mice. J. Antimicrob. Chemother. 32:723-739.